PUBLISHER: IMARC | PRODUCT CODE: 1390729
PUBLISHER: IMARC | PRODUCT CODE: 1390729
3D Bioprinting Market Report by Component (3D Bioprinters, Scaffolds, Biomaterials), Application (Research, Clinical), End User (Hospitals, Research Organization and Academic Institutes, Biopharmaceuticals Companies), and Region 2023-2028
Abstract
The global 3D bioprinting market size reached US$ 1,032 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 2,621 Million by 2028, exhibiting a growth rate (CAGR) of 16.81% during 2022-2028. The growing geriatric population, increasing focus on research and development (R&D) activities, and less disrupted market represent some of the key factors driving the market.
Rising Geriatric Population Augmenting Market Growth
The rising geriatric population currently represents one of the primary factors driving the 3D bioprinting market. There is an increase in the demand for organ transplantation among the geriatric population, as they are more prone to chronic diseases. Moreover, the wide availability of various medical technologies and the presence of competent specialists in the industry is supporting the growth of the market.
Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. The market structure is moderately fragmented with the presence of numerous regional and global players in the industry. The volume of new entrants is moderate in the 3D bioprinting industry due to the high capital investments and excessive entry and exit barriers. Moreover, the product differentiation is moderate in the industry due to little differentiation between several manufacturers.
What is 3D Bioprinting?
Three-dimensional (3D) bioprinting refers to an additive manufacturing method designed for the development of precise anatomical tissues. It comprises various deposition and assembling processes, such as direct and laser writing, microstamping, photolithography, stereolithography, electro-printing, and inkjet deposition. It relies on the decomposition of cell-based bio-inks that are manufactured using living cells, biomaterials, and active biomolecules to create 3D structures of tissues and organs. It deposits multiple layers of biomaterials to build numerous complex bodily structures, such as bones, skin, cartilage, vascular grafts, tracheal splints, and heart tissues. As a result, 3D bioprinting is widely utilized in hospitals, research organizations, academic institutes, and biopharmaceutical companies across the globe.
COVID-19 Impact:
The COVID-19 pandemic outbreak caused severe problems for various industries and imposed unprecedented challenges on numerous countries. But 3D bioprinting has emerged as a vital technology in the healthcare industry during the COVID-19 pandemic. There was an increased demand for 3D bioprinted organs due to the unavailability or shortage of medical products. In addition to this, various companies were using state-of-the-art 3D bioprinting platforms to fabricate SARS-CoV-2-infected human airway and lung organoid models. Moreover, these models were being used to study COVID-19 disease progression and for rapid drug screening. There was an increased utilization of bioprinters on account of the rising COVID-19 cases across the globe. Apart from this, the pandemic has slightly hampered the 3D bioprinting market due to the reduction in the production process. Various key manufacturers were forced to temporarily shut down or pause their production process for the first few months of the pandemic due to the widespread of the virus.
3D Bioprinting Market Trends:
At present, the increasing awareness among consumers to minimize animal testing represents one of the major factors influencing the market positively. Besides this, the growing demand for 3D bioprinting among the geriatric population, as they are more prone to various chronic diseases, is offering a positive market outlook. In addition, various technological advancements, such as the development of organ-on-a-chip, is propelling the growth of the market. Apart from this, the increasing demand for regenerative medicines, cancer therapeutics, and stem cell solutions among the masses around the world is contributing to the growth of the market. Moreover, the rising adoption of 3D bioprinting in the healthcare industry, as it is a less disrupted market, is supporting the growth of the market. Furthermore, key manufacturers are focusing on research and development (R&D) activities to introduce bioprinted tissues to reduce the cost of new innovations and enhance the process of finding new drugs.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global 3D bioprinting market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on component, application and end user.
Component Insights:
3D Bioprinters
Syringe/Extrusion Bioprinting
Inkjet Bioprinting
Magnetic Levitation Bioprinting
Laser-assisted Bioprinting
Others
Scaffolds
Biomaterials
Living Cells
Hydrogels
Extracellular Matrices
Others
The report has provided a detailed breakup and analysis of the 3D bioprinting market based on the component. This includes 3D bioprinters (syringe or extrusion bioprinting, inkjet bioprinting, magnetic levitation bioprinting, laser-assisted bioprinting, and others), scaffolds, and biomaterials (living cells, hydrogels, extracellular matrices, and others). According to the report, 3D bioprinters (syringe or extrusion bioprinting, inkjet bioprinting, magnetic levitation bioprinting, laser-assisted bioprinting, and others) represented the largest segment due to the increasing utilization of syringe or extrusion-based bioprinting technology in printing various biological compounds or devices. In addition to this, the rising awareness among individuals about the 3D bioprinters technology is bolstering the growth of the market.
Application Insights:
Research
Drug Research
Regenerative Medicine
3D Cell Culture
Clinical
Skin
Bone and Cartilage
Blood Vessels
Others
A detailed breakup and analysis of the 3D bioprinting market based on the application has also been provided in the report. This includes research (drug research, regenerative medicine, and 3D cell culture) and clinical (skin, bone and cartilage, blood vessels, and others). According to the report, research (drug research, regenerative medicine, and 3D cell culture) accounted for the largest market share, as 3D printing technology is widely utilized among researchers to study the effects of different diseases and their progression and possible treatments. Moreover, it reduces the need to use lab animals for medical tests and dangerous trials on humans.
End User Insights:
Hospitals
Research Organization and Academic Institutes
Biopharmaceuticals Companies
A detailed breakup and analysis of the 3D bioprinting market based on the end user has also been provided in the report. This includes hospitals, research organization and academic institutes, and biopharmaceuticals companies. According to the report, biopharmaceuticals companies accounted for the largest market share due to the increasing number of target therapies. In addition, the rising collaborations and mergers among biopharmaceutical companies to develop 3D bioprinting is positively influencing the market.
Regional Insights:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for 3D bioprinting. Some of the factors driving the North America 3D bioprinting market included the growing prevalence of various chronic diseases, presence of key players, and increasing private and government investment. Moreover, the introduction of laser bio-printing method that can make live 3D printed bio-tissues to create artificial tissues is positively influencing the market.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global 3D bioprinting market. Some of the companies covered in the report include:
3D Systems Inc.
Aspect Biosystems Ltd.
Cellink
Cyfuse Biomedical K.K.
EnvisionTEC GmbH (Desktop Metal Inc.)
GeSiM - Gesellschaft fur Silizium-Mikrosysteme mbH
Materialise
Organovo Holdings Inc.
Poietis
RegenHU
Stratasys Ltd.
Please note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
- 1. What was the size of the global 3D bioprinting market in 2022?
- 2. What is the expected growth rate of the global 3D bioprinting market during 2023-2028?
- 3. What are the key factors driving the global 3D bioprinting market?
- 4. What has been the impact of COVID-19 on the global 3D bioprinting market?
- 5. What is the breakup of the global 3D bioprinting market based on the component?
- 6. What is the breakup of the global 3D bioprinting market based on the application?
- 7. What is the breakup of the global 3D bioprinting market based on the end user?
- 8. What are the key regions in the global 3D bioprinting market?
- 9. Who are the key players/companies in the global 3D bioprinting market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global 3D Bioprinting Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Component
- 6.1 3D Bioprinters
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Syringe/Extrusion Bioprinting
- 6.1.2.2 Inkjet Bioprinting
- 6.1.2.3 Magnetic Levitation Bioprinting
- 6.1.2.4 Laser-assisted Bioprinting
- 6.1.2.5 Others
- 6.1.3 Market Forecast
- 6.2 Scaffolds
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Biomaterials
- 6.3.1 Market Trends
- 6.3.2 Key Segments
- 6.3.2.1 Living Cells
- 6.3.2.2 Hydrogels
- 6.3.2.3 Extracellular Matrices
- 6.3.2.4 Others
- 6.3.3 Market Forecast
7 Market Breakup by Application
- 7.1 Research
- 7.1.1 Market Trends
- 7.1.2 Key Segments
- 7.1.2.1 Drug Research
- 7.1.2.2 Regenerative Medicine
- 7.1.2.3 3D Cell Culture
- 7.1.3 Market Forecast
- 7.2 Clinical
- 7.2.1 Market Trends
- 7.2.2 Key Segments
- 7.2.2.1 Skin
- 7.2.2.2 Bone and Cartilage
- 7.2.2.3 Blood Vessels
- 7.2.2.4 Others
- 7.2.3 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Research Organization and Academic Institutes
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Biopharmaceuticals Companies
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 3D Systems Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Aspect Biosystems Ltd.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Cellink
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.4 Cyfuse Biomedical K.K.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 EnvisionTEC GmbH (Desktop Metal Inc.)
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 GeSiM - Gesellschaft fur Silizium-Mikrosysteme mbH
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 Materialise
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.8 Organovo Holdings Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.9 Poietis
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 RegenHU
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.11 Stratasys Ltd.
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.1 3D Systems Inc.
List of Figures
- Figure 1: Global: 3D Bioprinting Market: Major Drivers and Challenges
- Figure 2: Global: 3D Bioprinting Market: Sales Value (in Million US$), 2017-2022
- Figure 3: Global: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 4: Global: 3D Bioprinting Market: Breakup by Component (in %), 2022
- Figure 5: Global: 3D Bioprinting Market: Breakup by Application (in %), 2022
- Figure 6: Global: 3D Bioprinting Market: Breakup by End User (in %), 2022
- Figure 7: Global: 3D Bioprinting Market: Breakup by Region (in %), 2022
- Figure 8: Global: 3D Bioprinting (3D Bioprinters) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 9: Global: 3D Bioprinting (3D Bioprinters) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 10: Global: 3D Bioprinting (Scaffolds) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 11: Global: 3D Bioprinting (Scaffolds) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 12: Global: 3D Bioprinting (Biomaterials) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 13: Global: 3D Bioprinting (Biomaterials) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 14: Global: 3D Bioprinting (Research) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 15: Global: 3D Bioprinting (Research) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 16: Global: 3D Bioprinting (Clinical) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 17: Global: 3D Bioprinting (Clinical) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 18: Global: 3D Bioprinting (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 19: Global: 3D Bioprinting (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 20: Global: 3D Bioprinting (Research Organization and Academic Institutes) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 21: Global: 3D Bioprinting (Research Organization and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 22: Global: 3D Bioprinting (Biopharmaceuticals Companies) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 23: Global: 3D Bioprinting (Biopharmaceuticals Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 24: North America: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
- Figure 25: North America: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 26: United States: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
- Figure 27: United States: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 28: Canada: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
- Figure 29: Canada: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 30: Asia-Pacific: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
- Figure 31: Asia-Pacific: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 32: China: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
- Figure 33: China: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 34: Japan: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
- Figure 35: Japan: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 36: India: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
- Figure 37: India: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 38: South Korea: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
- Figure 39: South Korea: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 40: Australia: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
- Figure 41: Australia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 42: Indonesia: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
- Figure 43: Indonesia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 44: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
- Figure 45: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 46: Europe: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
- Figure 47: Europe: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 48: Germany: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
- Figure 49: Germany: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 50: France: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
- Figure 51: France: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 52: United Kingdom: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
- Figure 53: United Kingdom: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 54: Italy: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
- Figure 55: Italy: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 56: Spain: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
- Figure 57: Spain: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 58: Russia: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
- Figure 59: Russia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 60: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
- Figure 61: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 62: Latin America: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
- Figure 63: Latin America: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 64: Brazil: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
- Figure 65: Brazil: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 66: Mexico: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
- Figure 67: Mexico: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 68: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
- Figure 69: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 70: Middle East and Africa: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
- Figure 71: Middle East and Africa: 3D Bioprinting Market: Breakup by Country (in %), 2022
- Figure 72: Middle East and Africa: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 73: Global: 3D Bioprinting Industry: SWOT Analysis
- Figure 74: Global: 3D Bioprinting Industry: Value Chain Analysis
- Figure 75: Global: 3D Bioprinting Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: 3D Bioprinting Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: 3D Bioprinting Market Forecast: Breakup by Component (in Million US$), 2023-2028
- Table 3: Global: 3D Bioprinting Market Forecast: Breakup by Application (in Million US$), 2023-2028
- Table 4: Global: 3D Bioprinting Market Forecast: Breakup by End User (in Million US$), 2023-2028
- Table 5: Global: 3D Bioprinting Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 6: Global: 3D Bioprinting Market: Competitive Structure
- Table 7: Global: 3D Bioprinting Market: Key Players
